 | | | | Italy will not make COVID vaccinations obligatory, Prime Minister Giuseppe Conte said on Wednesday, adding he was confident there would be a large-scale demand for the shots among Italians on a voluntary basis. | | |
| | | ZURICH (Reuters) -A Swiss person who was among the first in the country to be vaccinated with a COVID-19 shot later died, officials in the canton of Lucerne said on Wednesday, though they did not indicate whether the death was related to the inoculation. | | |
| | | The Swiss government on Wednesday decided against further restrictions to prevent the spread of the novel coronavirus, even as faster-spreading variants have entered the country. | | |
| | | U.S. emergency medical personnel are getting quick access to COVID-19 vaccines in some parts of the United States while fire chiefs in other areas forecast a delay of weeks or months, highlighting the chaotic nature of a rollout that relies on states and counties to plan and administer distribution. | | |
| | | Ukraine's health minister has signed contract to buy 1.8 million doses of China's Sinovac COVID-19 vaccine, Ukraine's presidential office said on Wednesday. | | |
| | | Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, hoping that rapid action would help it stem a surge of infections driven by a highly contagious variant of the virus. | | |
| | | Germany expects the European Union to give quick approval to the coronavirus vaccine developed by Oxford University and Astrazeneca that was cleared for use in Britain on Wednesday, its top vaccines official said. | | |
| | | (Reuters) -Britain became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, while the first known U.S. case of a highly infectious variant was detected in Colorado on Tuesday. | | |
| | | Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, prioritizing the rapid deployment of the shot as it battles a major winter surge driven by a new, highly contagious variant of the virus. | | |
| | | Oxford and AstraZeneca's COVID-19 vaccine can be 80% effective when there are three months between shots, an official involved in approving the vaccine in Britain said, but there is insufficient evidence to back a regime involving a half dose. | | |
| | | Italy aims to vaccinate between 10 and 15 million people against COVID-19 by April, Prime Minister Giuseppe Conte said on Wednesday, adding he expects the vaccine to have an impact on the spread of the pandemic in late spring. | | |
|
| |
